About the fund
Investment Advisor
Founders
Investors
Board of Directors
Business Advisory Board
Scientific Advisory Board
Management Team
Portfolio
AngioGenetics Sweden AB
CanAg Diagnostics AB
Cellectricon AB
Genizon BioSciences
Gyros AB
Independent Pharma. AB
NsGene A/S
Phasein AB
Sidec Technologies AB
Wilex
News
2008
2007
2006
2005
2004
2003
Investment Proposals
Contact
NEWS,
Karolinska Investment Fund
November 23, 2004: PHASEIN
Swedish company first in the world. Medical instrument demonstrated directly over the Internet
November 10, 2004: Cellectricon
Cellectricon launches new system for ion channel drug screening
November 19, 2004: PHASEIN
VEO Multigas Monitor - Windows XP and Pocket PC based Multigas Monitoring Solution
November 12, 2004: PHASEIN
VEO Multigas-övervakning för Windows XP
November 8, 2004: Global Genomics
Global Genomics announces improved version of tangerine® gene expression profiling database covering 168 000 human transcripts
October 10, 2004: Cellectricon
Ulf Jönsson appointed CEO of Cellectricon
September 13, 2004: Sidec Technologies
Protein visualization company Sidec raises 5 MUSD with US and Swedish investors
September 13, 2004: Sidec Technologies
Hans Johansson appointed new CEO at Sidec Technologies
September 8, 2004: Global Genomics
Global Genomics´ tangerine© gene expression profiling method published
July 5, 2004: NsGene
US $3 million Michael J. Fox Foundation grant can yield breakthrough for treatment of Parkinson's disease
June 23, 2004: Sidec Technologies
Sidec Technologies performs 3-D analysis for the Bristol Institute for Transfusion Sciences and intensifies sales efforts in Europe
May 18, 2004: NsGene
US Patent Granted for Protein Important for Treating Neuropathic Pain
May 17, 2004: Demetech AB
FDA clears DXL Calscan - 1st of new generation bone densitometers
May 12, 2004: AngioGenetics AB
AngioGenetics AB and Tumor Biology Center Freiburg collaborate on the exploration of angiogenesis inhibitors for cancer treatment
April 27, 2004: Global Genomics
Global Genomics confirms superiority of tangerine™ gene expression profiling
March 18, 2004: Independent Pharmaceutica
Over 4 MUSD invested in a new anti smoking vaccine clinical trial
February 25, 2004: Global Genomics
Global Genomics proposes state-of-the-art performance standards for FDA pharmacogenomics initiative
January 26, 2004: CanAg Diagnostics
CE Mark for CanAg Diagnostics' products
Karolinska Fund - News
Phone
+46 8 50 88 44 50
Fax
+46 8 50 88 44 59
Email
marie-louise.sundin@
karolinskafund.com